Polyphenon® E for the treatment of HPV infections
	Links to press releases from MediGene AG and partnering companies:
December 2007	Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15% “Veregen™ is the first botanical drug approved for prescription use in the United States”
	MediGene’s Second Drug, Veregen™ (Polyphenon® E Ointment) Launched
April 2007	European Regulatory Authorities Accept MediGene’s Marketing Authorization Application for Polyphenon® E Ointment for Review
October 2006	MediGene AG Obtains Approval of Polyphenon® E Ointment in the USA
January 2006	Bradley Pharmaceuticals Enters Into Licensing Agreement With MediGene AG for POLYPHENON® E Ointment
	MediGene and Bradley Pharmaceuticals Enter Marketing and Development Partnership Polyphenon® E Ointment Bradley acquires US commercialization rights for genital warts and other dermatological diseases. MediGene retains full rest of world commercialization rights. Maximum milestone payments of up to $69 MM, including initial payment of $5 MM. Royalties on product sales Bradley Pharmaceuticals to support development costs for further indications.
December 2005	MediGene announces FDA Acceptance of New Drug Application for Polyphenon® E Ointment for the Treatment of Genital Warts
October 2005	MediGene Presents Results Obtained in Phase III Trial of Polyphenon® E Ointment Speech to be Given on the Occasion of the 14th Congress of the European Academy of Dermatology and Venerology in London
December 2004	MediGene Successfully Completes Pivotal Clinical Phase III Trials of Polyphenon® E Ointment for the Treatment of Genital Warts
March 2004	MediGene Achieves Positive Clinical Results With Polyphenon® E Ointment in European Phase 3 Trial
February 2004	MediGene: Patient Recruitment for Final Phase 3 Clinical Trial of Polyphenon® E Ointment Completed as Scheduled This allows completion of the trial by the end of the year, as planned
September 2003	MediGene acquires patents on Polyphenon® E for further indications
Back :: Licensed Products :: Current Research :: Management :: Contact :: Home
Polyphenon® is a registered trademark of Mitsui Norin Co., Ltd.